{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:04:44Z","timestamp":1779955484564,"version":"3.53.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jcf.2025.08.016","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T05:00:32Z","timestamp":1757826032000},"page":"1184-1188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elafin expression is regulated by CFTR-mutation and TGF\u03b21 in human bronchial epithelial cells"],"prefix":"10.1016","volume":"24","author":[{"given":"Jan Christoph","family":"Thomassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Vohlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7899-8833","authenticated-orcid":false,"given":"Ernst","family":"Rietschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A. Alejandre","family":"Alcazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"van Koningsbruggen-Rietschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jcf.2025.08.016_bib0001","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies of cystic fibrosis","volume":"4","author":"De Boeck","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.jcf.2025.08.016_bib0002","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jcf.2012.07.003","article-title":"Innate immunity in cystic fibrosis lung disease","volume":"11","author":"Hartl","year":"2012","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2025.08.016_bib0003","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1164\/ajrccm.152.2.7633718","article-title":"Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis","volume":"152","author":"Koller","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2025.08.016_bib0004","doi-asserted-by":"crossref","first-page":"L33","DOI":"10.1152\/ajplung.2000.278.1.L33","article-title":"Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8","volume":"278","author":"Taggart","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1016\/j.jcf.2025.08.016_bib0005","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1183\/13993003.01880-2015","article-title":"Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung","volume":"47","author":"Locke","year":"2016","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.jcf.2025.08.016_bib0006","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jcf.2014.09.003","article-title":"Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions","volume":"14","author":"Hentschel","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.08.016_bib0007","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1183\/09031936.01.17100270","article-title":"Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence","volume":"17","author":"Scheid","year":"2001","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jcf.2025.08.016_bib0008","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/14728222.12.2.145","article-title":"Targeting neutrophil elastase in cystic fibrosis","volume":"12","author":"Kelly","year":"2008","journal-title":"Expert Opin Ther Target"},{"key":"10.1016\/j.jcf.2025.08.016_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/293053","article-title":"The role of serine proteases and antiproteases in the cystic fibrosis lung","author":"Twigg","year":"2015","journal-title":"Mediat Inflamm"},{"issue":"3","key":"10.1016\/j.jcf.2025.08.016_bib0010","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1183\/09031936.00173210","article-title":"The role of matrix metalloproteinases in cystic fibrosis lung disease","volume":"38","author":"Gaggar","year":"2011","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.jcf.2025.08.016_bib0011","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/thx.2007.082388","article-title":"Neutrophils in cystic fibrosis","volume":"64","author":"Downey","year":"2009","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.jcf.2025.08.016_bib0012","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1358\/dnp.2006.19.10.1068008","article-title":"Neutrophilic inflammation as a major determinant in the progression of cystic fibrosis","volume":"19","author":"Tirouvanziam","year":"2006","journal-title":"Drug News Perspect"},{"issue":"1","key":"10.1016\/j.jcf.2025.08.016_bib0013","doi-asserted-by":"crossref","first-page":"L33","DOI":"10.1152\/ajplung.2000.278.1.L33","article-title":"Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8","volume":"278","author":"Taggart","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"9","key":"10.1016\/j.jcf.2025.08.016_bib0014","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1164\/rccm.201203-0507OC","article-title":"Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis","volume":"186","author":"Sagel","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.jcf.2025.08.016_bib0015","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.jcf.2025.08.016_bib0016","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1513\/pats.200603-078AW","article-title":"Neutrophil elastase-mediator of extracellular matrix destruction and accumulation","volume":"3","author":"Chua","year":"2006","journal-title":"Proc Am Thorac Soc"},{"issue":"5","key":"10.1016\/j.jcf.2025.08.016_bib0017","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1164\/rccm.201012-2010OC","article-title":"Inhibiting lung elastase activity enables lung growth in mechanically ventilated newborn mice","volume":"184","author":"Hilgendorff","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.jcf.2025.08.016_bib0018","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1164\/rccm.201412-2291OC","article-title":"Elafin reverses pulmonary hypertension via Caveolin-1-dependent bone morphogenetic protein signaling","volume":"191","author":"Nickel","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jcf.2025.08.016_bib0019","doi-asserted-by":"crossref","first-page":"00636","DOI":"10.1183\/23120541.00636-2020","article-title":"Reduced neutrophil elastase inhibitor elafin and elevated transforming growth factor-\u03b21 are linked to inflammatory response in sputum of cystic fibrosis patients with Pseudomonas aeruginosa","volume":"7","author":"Thomassen","year":"2021","journal-title":"ERJ Open Res"},{"issue":"6","key":"10.1016\/j.jcf.2025.08.016_bib0020","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jcf.2015.01.007","article-title":"Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients","volume":"14","author":"Waters","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.08.016_bib0021","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1002\/ppul.23242","article-title":"Inflammation and its genesis in cystic fibrosis","volume":"50","author":"Nichols","year":"2015","journal-title":"Pediatric Pulmonol"},{"issue":"5","key":"10.1016\/j.jcf.2025.08.016_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063167","article-title":"Tgf-\u03b21 inhibits cftr biogenesis and prevents functional rescue of \u0394F508-cftr in primary differentiated human bronchial epithelial cells","volume":"8","author":"Snodgrass","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jcf.2025.08.016_bib0023","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/thx.2006.074641","article-title":"Airway remodelling in children with cystic fibrosis","volume":"62","author":"Hilliard","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2025.08.016_bib0024","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ppul.21079","article-title":"Transforming growth factor-\u03b21 in bronchoalveolar lavage fluid from children with cystic fibrosis\u2020","volume":"44","author":"Harris","year":"2009","journal-title":"Pediatr. Pulmonol."},{"issue":"6","key":"10.1016\/j.jcf.2025.08.016_bib0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/thorax.55.6.459","article-title":"TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis","volume":"55","author":"Arkwright","year":"2000","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.jcf.2025.08.016_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106842","article-title":"Tgf-beta downregulation of distinct chloride channels in cystic fibrosis-affected epithelia","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2025.08.016_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026371","article-title":"Inhibition of TGF-\u03b2 signalling and decreased apoptosis in IUGR-associated lung disease in rats","volume":"6","author":"Alejandre Alc\u00e1zar","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2025.08.016_bib0028","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1164\/ajrccm.150.1.7912987","article-title":"Protease-antiprotease imbalance in the lungs of children with cystic fibrosis","volume":"150","author":"Birrer","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2025.08.016_bib0029","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.biocel.2008.03.003","article-title":"Proteases and cystic fibrosis","volume":"40","author":"Voynow","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jcf.2025.08.016_bib0030","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1807119","article-title":"VX-659-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Davies","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcf.2025.08.016_bib0031","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1164\/rccm.201906-1190PP","article-title":"Targeting proteases in cystic fibrosis lung disease. Paradigms, progress, and potential","volume":"201","author":"McKelvey","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2025.08.016_bib0032","doi-asserted-by":"crossref","first-page":"32377","DOI":"10.1074\/jbc.M803707200","article-title":"Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis","volume":"283","author":"Guyot","year":"2008","journal-title":"J Biol Chem"},{"issue":"9779","key":"10.1016\/j.jcf.2025.08.016_bib0033","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"CAPACITY Study Group. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2025.08.016_bib0034","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/17512433.2017.1295846","article-title":"Pirfenidone for the treatment of idiopathic pulmonary fibrosis","volume":"10","author":"George","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jcf.2025.08.016_bib0035","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1183\/16000617.0057-2017","article-title":"Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis","volume":"26","author":"Lancaster","year":"2017","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jcf.2025.08.016_bib0036","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1165\/rcmb.2019-0328TR","article-title":"Pirfenidone: molecular mechanisms and potential clinical applications in lung disease","volume":"62","author":"Ruwanpura","year":"2020","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325015759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325015759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:36:14Z","timestamp":1779953774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199325015759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1569199325015759"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.08.016","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elafin expression is regulated by CFTR-mutation and TGF\u03b21 in human bronchial epithelial cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}